Clinical trials sponsored by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase breakdown

Conditions studied

Recruiting trials led by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

• "Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu
  NCT03097952 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 6 locations
• A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS)
  NCT06987292 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Study of Trilaciclib Combined With mFOLFIRINOX in the Treatment of Patients With Advanced Pancreatic Cancer
  NCT06151262 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical Prostatectomy
  NCT07711314 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Male · 1 location
• Autologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy History
  NCT06821685 · Phase: Phase 1 · Ages: 22 Years to 40 Years · Sex: Female · 1 location
• China Diabetes Cognitive Dysfunction Early Diagnosis and Intervention Study (China-DECODE Study)
  NCT06650969 · Phase: Not specified · Ages: 45 Years and older · Sex: All (male and female) · 1 location
• Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase
  NCT05661786 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• CtDNA-guided Maintenance Therapy in Pancreatic Cancer
  NCT07054879 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Diagnostic Value of MRI-targeted Plus Index-lesion-ipsilaterally Systematic Biopsy for Biopsy-naive Men At Risk of Prostate Cancer
  NCT06584279 · Phase: Not specified · Ages: 60 Years to 80 Years · Sex: Male · 1 location
• Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD
  NCT07632677 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 22 locations
• Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma Biomarkers
  NCT06561906 · Phase: Not specified · Ages: 50 Years to 79 Years · Sex: All (male and female) · 1 location
• Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery
  NCT07163650 · Phase: Phase 4 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Food Intake-Related Brain and Metabolic Responses in Obesity
  NCT07392905 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 40 Years · Sex: All (male and female) · 1 location
• KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer
  NCT07353645 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery
  NCT06361238 · Phase: Phase 3 · Ages: 60 Years and older · Sex: All (male and female) · 1 location
• Long-Term Survival After LVAD Implantation in End-Stage Heart Failure
  NCT07382284 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)
  NCT07083154 · Phase: Phase 3 · Ages: 50 Years to 75 Years · Sex: All (male and female) · 8 locations
• Multicenter, Prospective, Observational Study on the Treatment of Type 2 Diabetes With Proline Plus Empagliflozin Tablets
  NCT07023172 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer
  NCT06389760 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC
  NCT06992232 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: Male · 1 location
• Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
  NCT05753566 · Phase: Phase 2 · Ages: 40 Years and older · Sex: Male · 2 locations
• Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD
  NCT05766449 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
  NCT06305832 · Phase: Phase 2 · Ages: 40 Years and older · Sex: Male · 2 locations
• The Cognitive Protective Effect of VR-based Cognitive Training in Type 2 Diabetes Patients With Mild Cognitive Impairment
  NCT07650318 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 80 Years · Sex: All (male and female) · 1 location
• Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor Agonists
  NCT07619989 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 50 Years · Sex: All (male and female) · 1 location
• Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Lifestyle Intervention
  NCT07630597 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 50 Years · Sex: All (male and female) · 1 location
• Universal Anti-CD70 CAR-T (CHT101) Cell Therapy for Relapsed Refractory Systemic Lupus Erythematosus
  NCT06946485 · Phase: Early Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School recruiting for?

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School is the lead sponsor of 27 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.